-
RAPT Therapeutics (NASDAQ:RAPT) Lowered to "Underweight" Rating by JPMorgan Chase & Co.
Source: Buzz FX / 11 Nov 2024 12:46:16 America/New_York
RAPT Therapeutics (NASDAQ:RAPT) Lowered to "Underweight" Rating by JPMorgan Chase & Co. Written by MarketBeat November 11, 2024 Share Link copied to clipboard. RAPT Therapeutics ( NASDAQ:RAPT - Get Free Report ) was downgraded by investment
Read more...